Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
PaperCitations, authors & open-access status
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 128 citations, 2020 year and closed oa status.
128
Citations
2020
Year
closed
OA Status